Analyzing P3 Health Partners (PIII) and Its Peers

P3 Health Partners (NASDAQ:PIII) is one of 59 public companies in the “Medical Care Facilities” industry, but how does it contrast to its competitors? We will compare P3 Health Partners to similar companies based on the strength of its analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends.

Profitability

This table compares P3 Health Partners and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-10.92%	-2,471.27%	33.63%
P3 Health Partners Competitors	4.71%	-121.41%	3.21%

Insider and Institutional Ownership

23.6% of P3 Health Partners shares are owned by institutional investors. Comparatively, 30.5% of shares of all “Medical Care Facilities” companies are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by company insiders. Comparatively, 21.9% of shares of all “Medical Care Facilities” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for P3 Health Partners and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	0	1	1	0	2.50
P3 Health Partners Competitors	128	904	1169	2	2.47

P3 Health Partners presently has a consensus target price of $5.00, suggesting a potential upside of 136.97%. As a group, “Medical Care Facilities” companies have a potential upside of 51.04%. Given P3 Health Partners’ stronger consensus rating and higher possible upside, analysts clearly believe P3 Health Partners is more favorable than its competitors.

Risk and Volatility

P3 Health Partners has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, P3 Health Partners’ competitors have a beta of 0.79, meaning that their average stock price is 21% less volatile than the S&P 500.

Valuation and Earnings

This table compares P3 Health Partners and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
P3 Health Partners	$1.05 billion	-$270.13 million	0.00
P3 Health Partners Competitors	$2.65 billion	$44.96 million	490.60

P3 Health Partners’ competitors have higher revenue and earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

P3 Health Partners competitors beat P3 Health Partners on 9 of the 13 factors compared.

About P3 Health Partners

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.